Ralovera en es it fr

Ralovera Brand names, Ralovera Analogs

Ralovera Brand Names Mixture

  • Lunelle (Medroxyprogesterone + Estradiol)

Ralovera Chemical_Formula


Ralovera RX_link


Ralovera fda sheet

Ralovera FDA

Ralovera msds (material safety sheet)

Ralovera Synthesis Reference

P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)

Ralovera Molecular Weight

344.488 g/mol

Ralovera Melting Point

220 - 223.5 oC

Ralovera H2O Solubility


Ralovera State


Ralovera LogP


Ralovera Dosage Forms

Tablets; Depo injection

Ralovera Indication

Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.

Ralovera Pharmacology

Medroxyprogesterone is a synthetic progestin more potent than progesterone.

Ralovera Absorption

Rapidly absorbed from GI tract

Ralovera side effects and Toxicity

Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.

Ralovera Patient Information

Ralovera Organisms Affected

Humans and other mammals